Hospital de Chitre to send non-urgent cases to polyclinic for care


Those who do not require immediate attention will be attended from 7:00 in the morning to 3:00 in the afternoon

The Social Security Fund (CSS) reported that as of Wednesday, May 2, 2018, all patients classified as “green”, according to the Triage system, who attend the emergency service of the Dr. Gustavo N. Collado hospital Ríos, in Chitré, province of Herrera, will be referred to the Dr. Roberto Ramírez De Diego polyclinic, where they will receive care.

This change will be from Monday to Friday, from 7:00 in the morning to 3:00 in the afternoon, since the patients classified as “green” correspond to non-urgent cases and can be seen in the outpatient clinic.

While users who come to the emergency room from 3:00 in the afternoon to 12:00 midnight, and are classified as “green”, they will be treated in the Orthopedics offices, located on the ground floor, next to Pharmacy , of this hospital of the CSS in Chitré.


No Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Air Travel
TWO steps FORWARD, THREE steps BACK. Covid proving to be elusive as travel spikes prove world is not out of the woods. International flights were the most affected, with a drop of 87.8% compared to that registered in October last year Total demand for air travel fell 70.6% in October compared to the same month last year, a sign of how “desperately slow” the sector’s recovery is going to be due …

As the Marijuana industry reaches BILLIONS, the UN has finally woke up. The United Nations (UN) has recognized the medicinal properties of cannabis on Wednesday in a vote in Vienna of the Commission on Narcotic Drugs, the executive body on drug policy of the United Nations. The simple majority of the 53 States of the Commission have decided to withdraw cannabis …

Vaccines from various producers start to hit the air. Panama awaiting Astra-Zeneca. The United States airline United Airlines began operating on Friday charter flights with vaccines against covid-19 developed by the pharmaceutical company Pfizer, in order to accelerate its distribution if the product receives approval from the health authorities, according to The Wall Street Journal. The newspaper, which cites anonymous sources …